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500 University Drive Hershey, PA 17033, USABackground/Aims:Bleeding esophageal varices are a common complication of portal hypertension in patients with
underlying liver disease. Often patients with hepatic cirrhosis have hypersplenism with thrombocytopenia and leukopenia.
Felty’s syndrome is a disorder where patients with rheumatoid arthritis develop splenomegaly, neutropenia, and on rare
occasions, portal hypertension without underlying cirrhosis.
Methods:We present a case of a patient with portal hypertension secondary to Felty’s syndrome and discuss the impor-
tance of recognizing this condition since the treatment of choice is surgical management with splenectomy. A review of the
literature and underlying liver histologic features are discussed.
Results:Medical and surgical management of patients with Felty’s syndrome is diﬀerent from those with portal hyper-
tension due to cirrhosis.
Conclusion: Splenectomy is the treatment of choice for complications of portal hypertension in patients with Felty’s
Syndrome.
 2009 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
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A 53-year-old Caucasian male presented to the emer-
gency department with hematemeis. His medical history
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hematoxylin and eosin.hypertrophy, GERD, hyperlipidemia and COPD. His
medications included etodolac, fenoﬁbrate, rabeprazole,
tiotropium, hydroxychloroquine and occasional over
the counter NSAIDs. He denied drug or alcohol abuse
and had no prior episodes of gastrointestinal bleeding.
Family history was pertinent for his father having died
with idiopathic cirrhosis. The physical examination
revealed resting tachycardia, lower extremity petechiae,
epigastric tenderness, splenomegaly, and hemoccult
positive stool. Abnormal laboratory tests showed a
hemoglobin of 11.1 g/dl and platelet count of 73,000/
ll. Liver proﬁle and coagulation times were normal.
An upper endoscopy was performed revealing grade 3
esophageal varices (Fig. 1A) extending from the gastro-
esophageal junction (40 cm) to 28 cm with stigma of
recent bleeding and a mosaic appearance was seen in
the gastric mucosa consistent with portal gastropathy
(Fig. 1B). Variceal ligation was performed with aPublished by Elsevier B.V. All rights reserved.
Fig. 4. Six months post-splenectomy repeat upper endoscopy showed a
normal distal esophagus with complete resolution of esophageal varices.
Fig. 1. Photographs taken during initial upper endoscopy revealed (A)
grade 3 esophageal varices with stigmata of recent bleeding and (B)
congestive portal gastropathy.
832 H. Stock et al. / Journal of Hepatology 50 (2009) 831–835banding device. Abdominal venous ultrasound revealed
patent portal and superior mesenteric veins and normal
hepatic. Liver biopsy was performed and revealed mac-
rosteatosis, mild portal inﬂammation, focal mild ﬁbrous
expansion, normal sinusoids, and no evidence of cirrho-
sis (Fig. 2). Transhepatic wedge pressures were per-
formed and were consistent with signiﬁcant portal
hypertension (the sinusoidal pressure, i.e., diﬀerence
between the mean right hepatic wedge pressure and
the mean right atrial pressure was 11 mm Hg; the mean
wedge pressure was 18 mm Hg). The patient was
referred to surgery for splenectomy. Splenic arteryFig. 2. Histology sections of the liver revealed macrosteatosis, mild
portal inﬂammation, and normal sinusoids on the hematoxylin and eosin
stain (A) and focal mild ﬁbrous expansion without evidence of cirrhosis
on the trichrome stain (B).
Fig. 3. A massively enlarged spleen was removed at surgery weighing
1875 g and measuring 12.2  1.8  2.5 cm.embolization was performed preoperatively. At surgery
the liver appeared normal and a 1875 g (12.2 
1.8  2.5 cm) spleen was removed (Fig. 3). Follow-up
endoscopy post-operatively revealed no evidence of
esophageal varices or portal gastropathy (Fig. 4).2. Literature review
2.1. Felty’s syndrome overview
Felty’s syndrome, awell-described triad of neutropenia,
splenomegaly, and rheumatoid arthritis (RA), has made
multiple appearances in the literature since itwas described
in 1924 [1]. Less than 1% of patients with rheumatoid
arthritis (RA) have Felty’s syndrome, and these patients
frequently have severe joint destruction, a higher occur-
rence of rheumatoid nodules, lymphadenopathy, hepatic
pathology, vasculopathy, leg ulcers and other recurrent
infections. A high percentage of those with Felty’s syn-
drome (78–90%) have the HLA-DR4 antigen (compared
to 70% of typical RA patients and 30% of controls), sug-
gesting a genetic component to this syndrome [2–4].
2.2. Liver histology in Felty’s syndrome
Several authors have reported varices in association
with Felty’s syndrome, with varying underlying liver
pathology, most frequently nodular regenerative hyper-
plasia (NRH) [5–12]. Other liver abnormalities found
on biopsy include: diﬀuse lymphocytic inﬁltration in
the sinusoids and Kupﬀer cell prominence, periportal
ﬁbrosis, macronodular cirrhosis, and ‘‘nodules” without
ﬁbrosis or lobular disruption [5]. No correlation between
transaminase abnormalities and histology could be made
[5]. In 1974, Blendis et al. found what seemed to be a pat-
tern in Felty’s associated liver pathology: they reported 5
patients with Felty’s syndrome who had hepatic nodular
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case with Felty’s syndrome showing hyperplastic liver
cells with atrophic double liver cell plates surrounding
the nodular zones of the NRH [11]. Sweeney claimed
the ‘‘double cell plates suggested that the liver underwent
generalized hyperplasia before nodule formation
occurred,” and that drugs used in treatment of RA could
have spurred hepatocyte growth. Furthermore, he sug-
gested that NRH could compress intrahepatic venous
radicals and sinusoids, leading to portal hyperten-
sion[11]. Some have oﬀered possible explanations for
the development of NRH, including compression of
intrahepatic vessels by regenerating nodules, obliterative
portal venopathy caused by diﬀuse intrahepatic micro-
thrombi from platelet activation [13,14], or similar
changes in blood ﬂow secondary to deposition of
immune complexes leading to regenerative nodules [14].
Several suggested that vasculitis may play a role in the
development of NRH [15,16]. Rau suggests that abnor-
mal hepatic histology, enlarged lymph nodes, and
splenomegaly should be ‘‘considered as organic manifes-
tations of rheumatoid arthritis” noting that ‘‘a reaction
of the reticuloendothelial system with its organs (lymph
nodes, spleen, bone marrow and Kupﬀer cells) is not
uncommon in rheumatoid arthritis [9].”
In addition to Felty’s syndrome the histologic abnor-
mality of NRH has also been reported in CREST syn-
drome, polycythemia vera, collagen vascular disorders,
lymphoproliferative disorders and malignant neoplasms
and possibly long term use of corticosteroids, oral con-
traceptive pills, and antineoplastic/immunosuppressive
drugs [17–19]. The ﬁnding of cirrhosis in a patient with
Felty’s syndrome is rare [20].
2.3. Increased splenic blood ﬂow and portal hypertension
Splenomegaly from various causes may result in ele-
vated portal vein pressures by increased total blood ﬂow
through the splenic artery. Klofkorn reported marked
decline in portal pressures in patients with esophageal
varices and Felty’s syndrome treated with splenectomy
[8]. This surgical approach prevented future episodes
of gastrointestinal bleeding in their patients. In similar
cases, Reisman and colleagues suggested that the portal
hypertension was a direct result of increased splenic
blood ﬂow [21]. Some argue that the portal hypertension
in Felty’s syndrome results from a combination of
increased splenic blood ﬂow and postsinusoidal resis-
tance from microthrombosis [14,22]. These observations
beg the question of whether NRH is one end of a contin-
uum of hepatic changes related to the splenomegaly seen
in Felty’s syndrome and if these changes can constitute a
separate contributing factor to portal hypertension, in
addition to increased splenic blood ﬂow alone. The
question remains of whether increased splenic blood
ﬂow alone could induce histologic hepatocellularchanges that in turn lead to portal hypertension or
whether hepatic pathology (created by another stimulus
in patients with RA with or without Felty’s) could, in
conjunction with increased blood ﬂow from splenomeg-
aly, lead to portal hypertension in these patients.
Although splenectomy with or without splenorenal
shunt [13] may prevent further bleeding from esophageal
varices, some advocate conservative medical manage-
ment [23] especially in elderly patients.
2.4. Cirrhosis-induced portal hypertension versus Felty’s
Syndrome portal hypertension:
In contrast to cirrhosis patients, those with bleeding
from esophageal varices secondary to Felty’s syndrome
do not develop encephalopathy. Also unlike subjects
with cirrhosis, splenectomy decreases the portal hyper-
tension and results in decompression of esophageal var-
ices in patients with Felty’s Syndrome. Thorne and
colleagues reported ‘‘the association of abnormal liver
test results with abnormal serologic variables may indi-
cate those patients likely to have abnormal liver histo-
logic features.” However, transaminase abnormalities
are not a reliable indication of abnormal liver histology
and our patient did not have any transaminase abnor-
malities. Therefore, the liver abnormalities may be
detectable only by liver biopsy [12]. Most patients with
cirrhosis as the etiology of portal hypertension often
also have evidence of synthetic hepatic dysfunction, such
as hypoalbuminemia or prolonged coagulation time. A
clue that our patient did not have cirrhosis was the lack
of abnormal hepatic blood tests.
Nakanuma et al. suggest that ‘‘unusual histologic
lesions in the livers of idiopathic portal hypertension
(IPH) patients with autoimmune disease may represent
an accentuated immunologic reaction inherent in IPH,
or that such cases may be an abortive or incomplete
form of primary biliary cirrhosis or nodular regenerative
hyperplasia of the liver [24].” Gento Pen˜a et al. [25]
reported a case in addition to Harris’s where the patient
had RA only with NRH and marked portal hyperten-
sion and elevated transaminases [25]. Gortisas et al.
add another report of NRH in a patient with RA with-
out Felty’s [26]. Taken together, these reports do sup-
port the idea that it is not splenomegaly alone (which
exists in Felty’s syndrome) that is causing NRH and/
or other hepatic changes that lead to varices. Perhaps
another process that exists in both RA and Felty’s
(and perhaps is accentuated in Felty’s) is aﬀecting the
liver. Perhaps this process, especially in combination
with splenomegaly (but not requiring splenomegaly),
leads to portal hypertension and varices in these
patients.
More recent discussion regarding splenomegaly raises
interesting points and supports the idea that, though
splenomegaly may not be solely responsible for the por-
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role cannot be totally discounted. A report on tropical
splenomegaly syndrome [27] (which seems to be related
to malaria exposure) noted asymptomatic esophageal
varices in 12 of 68 patients, all with Hackett’s stage 4
or 5 splenomegaly (8 of 12 were multiparous females).
Endoscopy seemed to indicate low bleeding risk. None
had collaterals connected to the portal system.
A recent interesting addition to the literature by Sema
et al. [28] reports a case of Felty’s syndrome with
chronic hepatitis and compatible autoimmune hepatitis
in which the patient had a contracted liver, ascites, tor-
tuous enlarged splenic vein, and splenomegaly and
esophageal varices with subsequent banding [28]. The
patient died from hepatic failure with encephalopathy.
Needle biopsy of the liver showed chronic hepatitis, nor-
mal lobular architecture, ﬁbrosis and piecemeal necrosis,
portal inﬂammation, lymphocytes and plasma cells.
The authors argue that the outcome for this patient
was a combination of factors: ‘‘Splenomegaly in patients
with Felty’s syndrome might be due to expansion of the
sinusoidal pulp, as indicated by wider separation of the
periarterial lymphoid sheaths and hyperplastic germinal
center. In the present case, we are convinced that
increasing blood ﬂow to the spleen due to splenomegaly
caused portal hypertension, congestion of blood within
the liver, and chronic hepatitis gradually worsened to
liver failure [28].”
Cohen et al. add another interesting report of hepatic
pathology in Felty’s Syndrome, a 68 year old woman
with massive hepatomegaly and biopsy of liver showed
preserved hepatic architecture, signiﬁcant sinusoidal
inﬁltration with mature lymphocytes in centrilobular
and periportal zones, minimal portal triad expansion
with mature lymphocytes with limiting plate intact, min-
imal cholestasis present in centrilobular areas, no ﬁbro-
sis and no nodule formation [29]. There is no mention of
portal hypertension in this patient, and the authors cite
Blendis’ previous report of 5 cases of sinusoidal lympho-
cytosis of the liver in Felty’s Syndrome, noting that one
had portal hypertension, but in the presence of portal
ﬁbrosis additionally. The authors also comment: ‘‘Sinu-
soidal lymphocytosis of the liver in Felty’s syndrome
bears a close relationship to the liver histology found
in idiopathic tropical splenomegaly syndrome [which]
is believed to be the result of a chronic immune response
to Plasmodium malaria. It is therefore tempting to spec-
ulate that sinusoidal lymphocytosis of the liver in Felty’s
syndrome might also be related to immunologic
factors.”
3. Conclusion
Felty’s syndrome is a rare complication of rheuma-
toid arthritis which can rarely lead to portal hyperten-sion and varices. In patients with this complication,
nodular regenerative hyperplasia is the most common
underlying liver pathology. More rarely, this complica-
tion has been reported in patients with much more sub-
tle changes or even normal liver biopsies. Our patient
adds another to the small number of such case reports.
It has been noted several times in the literature, how-
ever, that percutaneous needle biopsy and even wedge
biopsy may not always capture the characteristic archi-
tectural changes of NRH. One has even suggested that
reticulin staining, and not H&E alone may be necessary
to visualize these changes. Therefore, the cases of NRH
may be underestimated, and there is a small possibility
that nodular changes could be present but not proven
in our patient.
The possibility remains as well that the subtle changes
noted in our patient and in other patients who have had
portal hypertension without NRH lie at one end of a
continuum of hepatic pathology eﬀected by some pro-
cess found, or perhaps, accentuated in Felty’s syndrome.
Of note, more evidence is building for similar liver histo-
logic changes (including NRH) in RA without Felty’s
and other rheumatologic conditions as well. It would
seem that the liver is being aﬀected in these diseases
and causing, or contributing to, the development of por-
tal hypertension in the absence of a component of
splenomegaly, though some studies suggest that spleno-
megaly can aﬀect the liver in mechanisms apart from
just increasing ﬂow. It is likely that the combination of
these hepatic changes with the presence of splenomegaly
work together to increase the likelihood of developing
portal hypertension and even varices in Felty’s
syndrome.
However, the seemingly successful treatment of vari-
ces with splenectomy in several patients, including ours,
would support the idea that increased splenic and thus
portal blood ﬂow is a causative factor of portal hyper-
tension. It may be that, in patients with varices and por-
tal hypertension, shunt procedures are advisable as well
(especially if another component in addition to
increased splenic and portal ﬂow is believed to play a
role). One could argue that our patient’s esophageal var-
ices resolved because of banding, apart from splenec-
tomy. However, the patients gastric varices underwent
no direct intervention and follow-up endoscopy post
splenectomy showed improvement in portal
gastropathy.
Our case brings an entry to the more narrowly
focused dialog on the liver pathology seen in Felty’s
patients who present with esophageal or gastric varices
and the role of splenectomy and shunt as treatment.
Our patient’s subtle changes on liver biopsy with associ-
ated portal hypertension and varices place him in the
company of only a few other cases that we found on
extensive review of the literature.
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studies evaluating the beneﬁt of screening patients with
Felty’s syndrome for portal hypertension in an eﬀort
to prevent bleeding complications, though the sentiment
for possible screening has been occasionally suggested in
the literature. Perhaps the measurement of portal pres-
sures, screening liver biopsy, or even endoscopy in some
cases could prevent fatal complications in patients with
Felty’s syndrome. A study examining this question may
be beneﬁcial.
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